A detailed history of Voya Investment Management LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 38,418 shares of LXRX stock, worth $31,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,418
Previous 39,646 3.1%
Holding current value
$31,886
Previous $66,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.51 - $2.39 $1,854 - $2,934
-1,228 Reduced 3.1%
38,418 $60,000
Q2 2024

Dec 03, 2024

BUY
$1.54 - $2.28 $1,891 - $2,799
1,228 Added 3.2%
39,646 $66,000
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $16,442 - $24,343
10,677 Added 36.86%
39,646 $66,000
Q1 2024

Dec 06, 2024

SELL
$1.3 - $3.58 $12,283 - $33,827
-9,449 Reduced 24.6%
28,969 $69,000
Q1 2024

May 15, 2024

SELL
$1.3 - $3.58 $10,907 - $30,036
-8,390 Reduced 22.46%
28,969 $69,000
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.49 $10,057 - $16,326
4,678 Added 14.31%
37,359 $85,000
Q3 2022

Nov 14, 2022

BUY
$1.94 - $3.43 $12,280 - $21,711
6,330 Added 24.02%
32,681 $78,000
Q2 2022

Aug 15, 2022

SELL
$1.31 - $2.69 $6,063 - $12,452
-4,629 Reduced 14.94%
26,351 $49,000
Q1 2022

May 16, 2022

BUY
$1.95 - $3.89 $3,517 - $7,017
1,804 Added 6.18%
30,980 $65,000
Q4 2021

Feb 14, 2022

BUY
$3.81 - $6.16 $8,644 - $13,977
2,269 Added 8.43%
29,176 $115,000
Q2 2021

Aug 16, 2021

BUY
$4.12 - $5.87 $26,808 - $38,196
6,507 Added 31.9%
26,907 $124,000
Q1 2021

May 17, 2021

SELL
$3.45 - $9.09 $5,816 - $15,325
-1,686 Reduced 7.63%
20,400 $120,000
Q4 2020

Feb 16, 2021

BUY
$1.05 - $3.67 $9,622 - $33,631
9,164 Added 70.92%
22,086 $76,000
Q2 2020

Aug 14, 2020

SELL
$1.75 - $2.3 $15,758 - $20,711
-9,005 Reduced 41.07%
12,922 $26,000
Q4 2019

Feb 14, 2020

BUY
$3.16 - $5.15 $14,577 - $23,756
4,613 Added 26.64%
21,927 $91,000
Q2 2018

Aug 14, 2018

SELL
$7.8 - $13.69 $18,985 - $33,321
-2,434 Reduced 12.33%
17,314 $208,000
Q1 2018

May 15, 2018

SELL
$7.86 - $11.39 $8.2 Million - $11.9 Million
-1,043,263 Reduced 98.14%
19,748 $169,000
Q4 2017

Feb 14, 2018

SELL
$8.77 - $12.28 $821,556 - $1.15 Million
-93,678 Reduced 8.1%
1,063,011 $10.5 Million
Q3 2017

Nov 14, 2017

BUY
$12.17 - $16.3 $14.1 Million - $18.9 Million
1,156,689
1,156,689 $14.2 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.